MS May Begin Years Earlier Than Thought

Follow Drugslib on

By Ernie Mundell HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 4, 2025.

via HealthDay

MONDAY, Aug. 4, 2025 — People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows.

“MS can be difficult to recognize as many of the earliest signs — like fatigue, headache, pain and mental health concerns — can be quite general and easily mistaken for other conditions,” study senior author Helen Tremlett noted.

“Our findings dramatically shift the timeline for when these early warning signs are thought to begin, potentially opening the door to opportunities for earlier detection and intervention,” said Tremlett, a professor of neurology at the University of British Columbia, in Vancouver.

Her team published its findings Aug. 1 in JAMA Network Open.

MS is an autoimmune illness in which the body’s immune system goes awry, attacking the protective myelin sheath that surrounds nerves within the brain and along the spinal cord.

Communication breaks down between the brain and the body, leading to progressive disability.

The new study that suggests MS may begin more than a decade before a clinical diagnosis.

Tremlett’s group combed through British Columbia health data for 12,000 people with or without MS. Records went back as far as 25 years prior to an MS patient’s diagnosis.

That’s far longer than the five to 10 years covered in earlier studies looking at disease onset.

The main findings:

  • Fifteen years before the onset of classic MS symptoms, there was a noticeable uptick in patient visits to their general practitioner, or in visits to specialists for issues like fatigue, pain and dizziness, as well as mental health issues such as anxiety and depression.

  • Twelve years before symptom onset, visits to psychiatrists began to rise.

  • Eight to nine years before, visits to neurologists and eye specialists rose, perhaps linked to issues such as blurred vision or eye pain.

  • Three to five years before, researchers noted a rise in visits to emergency departments and/or radiology facilities.

  • One year before, visits peaked for a wide range of different physician types, such as neurologists, radiologists and emergency doctors.

    • “These patterns suggest that MS has a long and complex prodromal phase — where something is happening beneath the surface but hasn’t yet declared itself as MS,” said study first author Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC.

    “We’re only now starting to understand what these early warning signs are, with mental health-related issues appearing to be among the earliest indicators,” she added in a news release.

    The researchers stressed that the early issues that drove MS patients to seek out care can be caused by a myriad of health conditions. Simply experiencing these conditions does not mean a person will go on to develop MS.

    Nevertheless, “By identifying these earlier red flags, we may eventually be able to intervene sooner — whether that’s through monitoring, support or preventive strategies,” Tremlett said a university news release. “It opens new avenues for research into early biomarkers, lifestyle factors and other potential triggers that may be at play during this previously overlooked phase of the disease.”

    Sources

  • University of British Columbia, news release, Aug. 1, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-08-05 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords